LB-010 - A PHASE 1 CLINICAL STUDY OF THE SELECTIVE CARDIAC MYOSIN INHIBITOR AFICAMTEN IN HEALTHY CHINESE SUBJECTS.
H. Wang1, H. Liu1, X. Zhao1, J. Luo2, Y. Li2, B. Liu2, X. Chen2, Y. Li2, P. German3, D. Xu3, X. Han1; 1Peking Union Medical College Hospital, Beijing, P. R. China, 2Ji Xing Pharmaceuticals, Shanghai, P. R. China, 3Cytokinetics, Inc., South San Francisco, CA, USA.